American Well Corp
$ 5.51
-0.72%
14 Apr - close price
- Market Cap 91,863,000 USD
- Current Price $ 5.51
- High / Low $ 5.57 / 5.32
- Stock P/E N/A
- Book Value 14.34
- EPS -5.96
- Next Earning Report 2026-05-07
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.16 %
- ROE -0.34 %
- 52 Week High 9.15
- 52 Week Low 3.71
About
American Well Corporation is a telehealth business enabling digital healthcare delivery. The company is headquartered in Boston, Massachusetts.
Analyst Target Price
$6.25
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-12 | 2025-10-29 | 2025-08-05 | 2025-05-01 | 2025-02-12 | 2024-10-30 | 2024-07-31 | 2024-05-01 | 2024-02-14 | 2023-11-01 | 2023-08-02 | 2023-05-03 |
| Reported EPS | -1.52 | -1.5516 | -1.24 | -1.17 | -1.96 | -2.29 | -3.36 | -0.25 | -0.17 | -0.48 | -0.33 | -0.24 |
| Estimated EPS | -0.14 | -1.46 | -1.74 | -1.88 | -2.55 | -3.11 | -3.98 | -0.19 | -0.2 | -0.21 | -0.22 | -0.21 |
| Surprise | -1.38 | -0.0916 | 0.5 | 0.71 | 0.59 | 0.82 | 0.62 | -0.06 | 0.03 | -0.27 | -0.11 | -0.03 |
| Surprise Percentage | -985.7143% | -6.274% | 28.7356% | 37.766% | 23.1373% | 26.3666% | 15.5779% | -31.5789% | 15% | -128.5714% | -50% | -14.2857% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-07 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.77 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AMWL
2026-04-03 18:54:00
This article provides an AI-driven quantitative analysis for American Well Corporation Class A (NASDAQ: AMWL), indicating weak sentiment across all horizons and supporting a short bias. It details several trading strategies, including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis suggesting resistance and support levels. The analysis highlights an exceptional risk-reward short setup targeting 20.5% downside.
2026-04-03 07:10:38
American Well (NYSE:AMWL) insider Phyllis Gotlib sold 3,706 shares of the company's stock on April 1st at an average price of $5.30, totaling $19,641.80. This sale decreased her stake by 2.22% to 163,004 shares. The company recently reported quarterly earnings that slightly beat estimates, but remains unprofitable with a negative net margin, and analysts largely rate the stock as a "Hold."
2026-04-02 23:10:38
Dmitry Zamansky, an insider at American Well (NYSE:AMWL), sold 5,575 shares of the company's stock on April 1st at an average price of $5.30, reducing his stake by 2.26%. This sale followed a previous transaction on January 2nd. Despite beating EPS estimates, American Well remains unprofitable, with analysts expecting a negative EPS for the current year, and the stock currently has a "Hold" rating from analysts with an average price target of $7.42.
2026-04-02 22:10:38
American Well (AMWL) announced that Dr. Peter Slavin will resign from its Board of Directors at the company's 2026 annual meeting, effective April 1, 2026. This transition is described as orderly and not due to any disagreements, following Dr. Slavin's move to a new role on the U.S. West Coast. TipRanks' AI Analyst, Spark, assesses AMWL as Neutral due to weak financial performance and bearish technicals, despite some positive points like improved mix and cost reductions.
2026-04-02 21:10:38
Dmitry Zamansky, Chief Product & Tech. Officer at American Well (NYSE: AMWL), reported an automatic "sell to cover" transaction of 5,575 shares of Class A Common Stock at $5.30 per share. This sale was made to cover tax liabilities from restricted stock units that vested on April 1, 2026, and was not a discretionary trade. Following the transaction, Zamansky directly holds 241,080 shares.
2026-04-02 21:10:38
American Well Corp's Chief Accounting Officer, Paul Francis McNeice, sold 383 shares of Class A Common Stock at $5.30 per share on April 1, 2026. This non-discretionary transaction was undertaken to cover tax liabilities arising from the vesting of restricted stock units. Following the sale, McNeice directly holds 10,616 shares of American Well Corp.
